ClinicalTrials.Veeva

Menu

Randomized Trial Evaluating the Effectiveness of the General Practitioner Involvement in Cancer Screening Invitations (GPs)

R

Regional University Hospital Center (CHRU)

Status

Completed

Conditions

Breast Cancer
Cervical Cancer
Colorectal Cancer

Treatments

Other: Normal invitation
Other: Revised invitation signed by the attending physician
Other: revised invitation signed by the coordinating doctor

Study type

Interventional

Funder types

Other

Identifiers

NCT02367001
INCA-P3644-KH-GPs

Details and patient eligibility

About

Our goal is to evaluate, in France, the effectiveness (in terms of participation) of the general practitioner involvement (signature) and a more personalized communication in invitation letters to organized screening of breast, colorectal and cervical cancers.

The hypothesis on which this project is based is that communication is probably more effective if the "receiver" feels personally targeted by invitation letters (Dear Martin, I am writing ...) and if he knows "the issuer "(his general practitioner rather an unknown person).

Enrollment

53,978 patients

Sex

All

Ages

25 to 74 years old

Volunteers

No Healthy Volunteers

Inclusion and exclusion criteria

Inclusion Criteria:

  • Living in Indre-et-Loire (french territorial division 37)
  • Be affiliated to the following three health insurance companies: CPAM (Caisse Primaire d'Assurance Maladie), MSA (Mutualité Sociale Agricole), or RSI (Régime social des Indépendants)
  • Having declared (to health insurance company) an attending physician who has given its written consent to participate in the study
  • Present no exclusion criterion to cancer screening ( for each one)
  • Be old from 50 to 74 years (breast and colorectal cancer) or from 25 to 65 years (cervical cancer)

Exclusion Criteria:

Trial design

Primary purpose

Screening

Allocation

Randomized

Interventional model

Parallel Assignment

Masking

Single Blind

53,978 participants in 3 patient groups

1: standard invitation
Other group
Description:
Group 1: sending a standard invitation signed by the coordinating doctor (send by the structure responsible for organized screenings) Intervention : Normal invitation
Treatment:
Other: Normal invitation
2: Revised invitation
Experimental group
Description:
Group 2: Sending a revised invitation ( text, layout) signed by the coordinating doctor (send by the structure responsible for organized screenings) Intervention : revised invitation signed by the coordinating doctor
Treatment:
Other: revised invitation signed by the coordinating doctor
3 : revised invitation signed by the attending physician
Experimental group
Description:
Group 3: Sending a revised invitation signed by the attending physician (send by the structure responsible for organized screenings) Intervention : Revised invitation signed by the attending physician
Treatment:
Other: Revised invitation signed by the attending physician

Trial contacts and locations

1

Loading...

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2026 Veeva Systems